Clinical Trial Update: Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Cicaderma versus standard care to prevent radiodermatitis in non-metastatic breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cicaderma

Snippet

Sponsor: Centre Leon Berard | Conditions: Breast Adenocarcinoma, Radiation Dermatitis | Phase 3 | Status: UNKNOWN